"Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.
about
The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting gliaOpioid receptor-triggered spinal mTORC1 activation contributes to morphine tolerance and hyperalgesiaSystemic minocycline differentially influences changes in spinal microglial markers following formalin-induced nociceptionValidation of a preclinical spinal safety model: effects of intrathecal morphine in the neonatal ratPain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults.Medication-overuse headache and opioid-induced hyperalgesia: A review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment.Light-emitting diode therapy induces analgesia and decreases spinal cord and sciatic nerve tumour necrosis factor-α levels after sciatic nerve crush in mice.Spinal toll like receptor 3 is involved in chronic pancreatitis-induced mechanical allodynia of ratChronic low back pain, sleep disturbance, and interleukin-6Mechanical hypersensitivity, sympathetic sprouting, and glial activation are attenuated by local injection of corticosteroid near the lumbar ganglion in a rat model of neuropathic pain.Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.Increased interleukin-6 activity associated with painful chemotherapy-induced peripheral neuropathy in women after breast cancer treatment.Current gene therapy using viral vectors for chronic painIntrathecal injection of adenosine 2A receptor agonists reversed neuropathic allodynia through protein kinase (PK)A/PKC signaling.Long-term results of therapeutic local anesthesia (neural therapy) in 280 referred refractory chronic pain patientsToll-like receptors in chronic pain.DAT isn't all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling.Glia as a Link between Neuroinflammation and Neuropathic Pain.Robust spinal neuroinflammation mediates mechanical allodynia in Walker 256 induced bone cancer ratsAtenolol Reduces Leishmania major-Induced Hyperalgesia and TNF-α Without Affecting IL-1β or Keratinocyte Derived Chemokines (KC)Do glial cells control pain?Neuroinflammation, neuroautoimmunity, and the co-morbidities of complex regional pain syndrome.Pain and inflammation in women with early-stage breast cancer prior to induction of chemotherapy.Communication between neuronal somata and satellite glial cells in sensory ganglia.Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)A human trial of HSV-mediated gene transfer for the treatment of chronic pain.Neuron-glia crosstalk gets serious: role in pain hypersensitivity.Inflammation at the intersection of behavior and somatic symptoms.Cytokine and chemokine regulation of sensory neuron function.Central sensitization: a generator of pain hypersensitivity by central neural plasticity.HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allodynia.Neuropathic pain: a maladaptive response of the nervous system to damage.Evidence for a role of heat shock protein-90 in toll like receptor 4 mediated pain enhancement in ratsTNF-alpha and neuropathic pain--a review.Long-term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states.Astrocyte-neuron communication: functional consequences.Proteome of brain glia: the molecular basis of diverse glial phenotypes.Neuroinflammatory effects of radiofrequency.Modulating the delicate glial-neuronal interactions in neuropathic pain: promises and potential caveats.
P2860
Q24650739-A6D70722-BEFF-4120-A3C8-36D7FA1AC2AEQ28576512-8D8D534B-74EB-41BA-B896-DC500C9C3F72Q33870861-7447CBFF-2971-434A-9175-FEC76BF1EC5FQ33987944-3437CF35-7E04-47EE-B0D1-E1F915665CE0Q34033859-35617A6F-44E2-4E72-867F-D32E19D57EC9Q34137925-CA59D540-326A-4DBC-AE91-79EF09714C19Q34311105-9BB49911-B18A-4318-87B9-E0F9A1C4C739Q34556844-B1E08779-C49E-460A-A9EF-8BFF9237C0AAQ34623691-DA8214A0-3595-4E11-8254-7BB976F8CBCDQ34682083-18E29CBA-52EC-45A3-85AA-048D1A5507A5Q34795430-40B1B8E5-1CAB-4620-BCAE-1560E458258DQ35122783-BBD2DA0F-3359-4842-AF9E-03D691D9F5BBQ35202129-471B053F-4CA8-4902-B1CF-E94D0B6B0777Q35658521-6E66231B-B0D8-42A9-8F46-364B44505352Q35662011-41C363C4-148E-4A2C-848F-84CABB49C6E5Q35675950-DE0D9B18-3E6D-466E-82C7-50BA8139ECDDQ35830682-AB734C7C-0178-4002-B906-9059550BF3FBQ35912309-DC2A8782-408A-4182-946C-EB26E476124AQ36056893-E1745FE7-06CD-493F-B6C0-9C03E09110C2Q36237080-0AB428CC-F95A-4E0B-8A61-698467B5E214Q36579090-F96A8EF1-2803-43C0-BD5B-58973C059F75Q36672341-D43886D5-AD84-499B-AA04-E3BA9771EEA3Q36868585-4C4D1A6F-6E5F-4A8B-ADEE-31B6485FFAF5Q37058901-DDA997C1-E9D8-4923-8C70-FF2EA29458A4Q37135199-1395FD60-86F9-4F3E-8EB4-AC38166E1900Q37143300-033AEDDA-9749-4ABC-9ED9-D19BA6CCE014Q37195741-9BBFBBCA-56A2-4A11-8AC7-55E69B5A906FQ37265977-3EE61EB6-0A66-405A-A56D-6ABA7463FE30Q37287493-B40E5AA0-8FA7-4B71-AE87-DA483F18CDEEQ37351994-8CDBCACA-6136-4D73-8992-9574D5F23CC8Q37361185-0A8C9EA0-7328-47F6-A700-01CF1B8AC505Q37381541-1E8C716B-D376-41A5-B089-A59E21B920A3Q37401775-E2918C47-02E4-45D3-8781-B1F8195BD5CEQ37438107-05BD6905-71CA-4EA1-A676-85A2411CA353Q37732472-D012F462-F911-4854-AE07-9D926030CA53Q37900692-B932F8FB-B6C5-40D6-A8F0-3F1E4FF6A4C6Q38016361-FB5741A6-13C4-4EA4-8E35-E8E1D8305CFDQ38152439-FB7ED2ED-39D0-44A4-A254-1E374F1F2F07Q38176246-26C7610F-C332-4BD1-8BEB-4DCAB99525FAQ38211273-BA1EE49B-0AB1-4FC5-ABD9-42F324D170D8
P2860
"Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
"Listening" and "talking" to n ...... asing the efficacy of opioids.
@ast
"Listening" and "talking" to n ...... asing the efficacy of opioids.
@en
type
label
"Listening" and "talking" to n ...... asing the efficacy of opioids.
@ast
"Listening" and "talking" to n ...... asing the efficacy of opioids.
@en
prefLabel
"Listening" and "talking" to n ...... asing the efficacy of opioids.
@ast
"Listening" and "talking" to n ...... asing the efficacy of opioids.
@en
P2860
P1476
"Listening" and "talking" to n ...... asing the efficacy of opioids.
@en
P2093
Erin D Milligan
Steven F Maier
P2860
P304
P356
10.1016/J.BRAINRESREV.2007.06.006
P577
2007-07-13T00:00:00Z